PRNewswire: August 24, 2017 – SOUTH SAN FRANCISCO, CA, U.S.A. – Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) announced today that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for its ropinirole implant intended for treatment of the signs and…
